Larry Don Otwell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 317 W Cherokee Ave, Suite B, Enid, OK 73701 Phone: 888-573-7792 Fax: 888-573-7792 |
Ella Patridge, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 Fax: 580-237-7711 |
Mindy Ann Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 |
Robert D Jones, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: Po Box 152, Enid, OK 73702 Phone: 580-234-3791 Fax: 580-237-7711 |
Christine Renee Pidcock, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4121 S Van Buren St, Enid, OK 73703 Phone: 580-231-5939 |
Brylyn Adams, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1106 W Willow Rd, Enid, OK 73703 Phone: 580-234-4343 |
Lizette Hernandez, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 |
Kelli Mclerran, L.P.N. Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 Fax: 580-237-7711 |
Roberta Dehaas, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 Fax: 580-237-7711 |
Lisa Ann Halcomb, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 |
News Archive
A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.
Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the fourth quarter and year ended December 31, 2009.
Hospitals that treat more poor seniors who are on both Medicaid and Medicare tend to have higher rates of readmissions, triggering costly penalties from the Centers for Medicare and Medicaid Services, finds a new study in Health Services Research.
Global regenerative medicine company Mesoblast Limited (ASX:MSB) has announced that its Phase 2 clinical trial investigating the use of allogeneic, or off-the-shelf, Mesenchymal Precursor Cells (MPCs) for non-surgical restoration of degenerated intervertebral discs and treatment of low back pain has enrolled 50% of the total study patients. This rapid rate of enrolment attests to the major unmet medical need and to the relative simplicity of Mesoblast's non-surgical procedure. Mesoblast expects to complete full enrolment by early third quarter.
› Verified 3 days ago